Related references
Note: Only part of the references are listed.Human natural killer cells in major histocompatibility complex class I deficiency
Neha D. Patil et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2021)
KEGG: integrating viruses and cellular organisms
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2021)
A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion
Devin Dersh et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Inhibition of MICA and MICB Shedding Elicits NK-Cell-Mediated Immunity against Tumors Resistant to Cytotoxic T Cells
Lucas Ferrari de Andrade et al.
CANCER IMMUNOLOGY RESEARCH (2020)
PDIA3 correlates with clinical malignant features and immune signature in human gliomas
Hao Zhang et al.
AGING-US (2020)
Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma
Hao Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas
Hao Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Toward understanding the origin and evolution of cellular organisms
Minoru Kanehisa
PROTEIN SCIENCE (2019)
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
Bryan D. Choi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints
Noemi Andor et al.
BLOOD (2019)
Immune checkpoint blockade resistance-related B2M hotspot mutations in microsatellite-unstable colorectal carcinoma
Su Yeon Yeon et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Glioblastoma Treatment Modalities besides Surgery
Hao Zhang et al.
JOURNAL OF CANCER (2019)
A new fast method for inferring multiple consensus trees using k-medoids
Nadia Tahiri et al.
BMC EVOLUTIONARY BIOLOGY (2018)
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
Georgina V. Long et al.
LANCET ONCOLOGY (2018)
Oncogenic pathways that affect antitumor immune response and immune checkpoint blockade therapy
Xianda Zhao et al.
PHARMACOLOGY & THERAPEUTICS (2018)
MHC Expression Predicts Checkpoint Blockade Response
Catherine Caruso
CANCER DISCOVERY (2018)
Epigenetic regulation of gene expression in cancer: techniques, resources and analysis
Luciane T. Kagohara et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2018)
Integrative clinical genomics of metastatic cancer
Dan R. Robinson et al.
NATURE (2017)
AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma
Ryan D. Chow et al.
NATURE NEUROSCIENCE (2017)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Moshe Sade-Feldman et al.
NATURE COMMUNICATIONS (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Genetic Evolution of T-cell Resistance in the Course of Melanoma Progression
Antje Sucker et al.
CLINICAL CANCER RESEARCH (2014)
Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma
Ana B. del Campo et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas
Tiffany Doucette et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution
Peter Parham et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Increased Immune Gene Expression and Immune Cell Infiltration in High-Grade Astrocytoma Distinguish Long-Term from Short-Term Survivors
Andrew M. Donson et al.
JOURNAL OF IMMUNOLOGY (2012)
Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic?
Christian Hartmann et al.
CLINICAL CANCER RESEARCH (2011)
Detailed Characterization of Alterations of Chromosomes 7, 9, and 10 in Glioblastomas as Assessed by Single-Nucleotide Polymorphism Arrays
Ines Crespo et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and β2-microglobulin in B-cell chronic lymphocytic leukemia
Stefano Molica et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
Achim Rody et al.
BREAST CANCER RESEARCH (2009)
Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model
Haiyen E. Zhau et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Anti-β2-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid rafts
Jing Yang et al.
BLOOD (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Targeting β2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma
Takeo Nomura et al.
JOURNAL OF UROLOGY (2007)
Targeting β2-microglobulin for induction of tumor apoptosis in human hernatological malignancies
Jing Yang et al.
CANCER CELL (2006)
Cancer interaction with the bone microenvironment - A workshop of the National Institutes of Health Tumor Microenvironment Study Section
ML Cher et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Contribution of β-2 microglobulin levels to the prognostic stratification of survival in patients with myelodysplastic syndrome (MDS)
S Gatto et al.
BLOOD (2003)
Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL)
S Faderl et al.
LEUKEMIA (2002)
Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome
GE Keles et al.
JOURNAL OF NEUROSURGERY (2001)
Changes in beta-2 microglobulin expression in prostate cancer
M Abdul et al.
UROLOGIC ONCOLOGY (2000)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
